Adam Chasse Named to New Executive Post at RxTrials, Inc.

Chief Operating Officer Role Signifies Company's Growth

ELLICOTT CITY, Md., Aug. 13, 2012 /PRNewswire/ -- Adam Chasse has been named to the newly created post of Chief Operating Officer (COO) for RxTrials, Inc., a leading network of clinical research sites and top industry consulting firm.

As COO, Chasse will oversee operational delivery within the site network and consulting divisions, corporate strategy and planning, human resources, business development, and contracting.

"Our industry sits at a juncture where new types of partnerships and outside-the-box thinking are vital for success," said Christine Pierre, founder and president of RxTrials. "As a company, we are growing and developing opportunities. Adam's industry experience and leadership qualities are the ideal combination for this important new position."

"Companies that want to thrive in our industry today must focus on time and cost efficiencies without sacrificing quality," Chasse said. "That creates exciting opportunities for RxTrials, as we leverage our expertise from the site, CRO, and sponsor segments of the industry to help a diverse group of industry stakeholders achieve better delivery. I am honored to take this new leadership role in a company that has such an impressive blend of experienced staff and managers."

Prior to joining RxTrials in 2011 as Vice President of Corporate Development, Chasse spent 16 years in the CRO industry, during which led a variety of functional areas and had global responsibility.  He has served on numerous steering and membership committees for industry organizations and is called upon regularly to speak at national conferences. Chasse holds a Master of Healthcare Administration degree from the Gillings School of Global Public Health at the University of North Carolina-Chapel Hill.

RxTrials, Inc. is a network of premier clinical research sites that, through partnerships with more than 100 top study sponsors and CROs, has conducted more than 1,000 studies helping to bring new drugs, vaccines, and medical devices to market. It is also a leading consulting company, offering solutions to research sites, sponsors, and CROs.  Additionally, it is the parent company of RxTrials Institute, a leading national clinical research consultant and education provider. RxTrials Institute each year presents the Site Solutions Summit, a top networking and business management conference for clinical research sites, sponsors and CROs.

More information can be found at

SOURCE RxTrials, Inc.